Anti-psychotic medication for children could have lasting effects, research suggests
Researchers have found evidence that medicating children with behaviour problems could have an impact on levels of depression, anxiety and hyperactivity later in life.
Neuroscientists at the University of Wollongong have published the results of the first comprehensive study on the long term use of anti-psychotic medications in children.
The study looked at three commonly prescribed drugs called Risperidone, Olanzapine and Aripiprazole.
They found using the drugs during childhood and adolescence could have significant lifelong impacts on levels of hyperactivity, depression and anxiety.
There has been growing concern about the rising use of such drugs among children because they are typically not approved for use in growing brains and are being prescribed “off-label”.